baber/WOPTO huggingface dataset:
Patent NZ-515554-A (NZ)
Title: Treatment  of  diabetes  with  thiazolidinedione   and metformin
Inventor: SMITH STEPHEN ALISTAIR
IPC: A61K31/155
Filed: 1998-06-15
Abstract: A pharmaceutical composition comprising from 2-12 mg of 5-[4-[2-(N-methyl-N-(2- pyridal)amino)ethyl]benzyl]thiazolidine-2,4-dione,         a biguanide  antihyperglycaemic agent and  a  pharmaceutically acceptable  carrier,  for use in the treatment  of  diabetes mellitus.
Patent NZ-517134-A (NZ)
Title: Air duct mounting apparatus
Inventor: HOLYOAKE SCOTT NOEL
IPC: E04F17/04
Filed: 2002-02-12
Abstract: A ceiling component mounting adapter configured to allow a ceiling component to be mounted without being directly attached to a ceiling. The adapter consists of a plate portion (6) that lies parallel to the ceiling (7) and an attachment means (5).
Patent NZ-517597-A (NZ)
Title: L-carnitine with a particle size that can pass through a 100 USBS mesh sieve, methods of preparing the same, compositions containing the same, and methods of using the same
Inventor: HASSEN KEN
IPC: A23L33/20
Filed: 2000-09-05
Abstract: L-carnitine has a particle size such that it substantially passes through a 100USBS mesh sieve. Also describe is a method to prepare the L-carnitine and the use of the carnitine in a pharmaceutical composition.
Patent NZ-522081-A (NZ)
Title: Methods of treating plants with glycolic acid to reduce the effects of plant stress
Inventor: KINNERSLEY ALAN M
IPC: A01G7/00
Filed: 2001-04-19
Abstract: Methods for increasing the resistance of a plant to the effects of plant stress utilising glycolic acid, a salt, or a mixture thereof, are described. Methods for stimulating plant growth utilising an ammonium salt of glycolic acid are also described. Further described are methods for stimulating microbial growth utilising selected amounts of glycolic acid, a salt, or a mixture thereof. Fig. 1 is a graph showing the fresh weight of cabbage after being treated with the indicated concentrations (in ppm, on a weight/volume basis) of Auxigro(r) (F03, a 1: 1: 1 solution of y-aminobutyric acid, glutamic acid and casein hydrolysate), glycolic acid (F12) or ammonia-neutralised glycolic acid (F18). NTC, non-treated control surf ctrl, surfactant control (surfactant is Breakthru(r), a silicone-based surfactant) ; a, b, c, cd, and d represent Duncan groupings.
Patent NZ-529960-A (NZ)
Title: Halogen-free aqueous fire retardant composition
Inventor: MANTANIS GEORGE
IPC: B27K3/52
Filed: 2002-06-17
Abstract: Disclosed herein is a fire retardant composition that is halogen-free comprises an aqueous solution of an amine, a borate and a phosphate, wherein the composition is effective in providing wood-based panels like medium- or high- density fibreboards with high fire resistance without a diminution in their physical and mechanical properties.
Patent NZ-530275-A (NZ)
Title: Improvement to the methods for the continuous production of acetic acid and/or methyl acetate
Inventor: THIEBAUT DANIEL
IPC: C07C51/12
Filed: 2002-06-26
Abstract: A method for the continuous preparation of acetic acid and/or methyl acetate by carbonylation using carbon monoxide, methanol or a methanol derivative that can be carbonylated, in liquid phase, in the presence of water and a catalytic system (group VIII metals such as rhodium, iridium or platinum are of particular relevance in this reaction process). Accordingly, in order to improve the production of acetic acid and/or methyl acetate, the temperature of the reactor and the inlet flow of methanol, or the methanol derivative that can be carbonylated, into the reactor are controlled by the inlet flow of carbon monoxide and by at least one of the parameters that define the composition of the reaction medium and/or events, said automatic control being performed preferably by means of a predictive multi-variable regulator. This method is suitable for use in Monsanto-type preparation methods and low water content methods.
Patent NZ-530624-A (NZ)
Title: Compositions comprising C34+ hematopoietic progenitor cells transformed with an anti-viral agent for treating HIV
Inventor: SYMONDS GEOFFREY P
IPC: A61K35/12
Filed: 2002-07-10
Abstract: Described are compositions and methods relating to gene therapy, particularly as applied to hematopoietic progenitor (HP) cells, to transduced cells and methods of obtaining them, and to methods of using them to provide prolonged engraftment of modified hematopoietic cells in human subjects. The invention particularly relates to ex vivo gene therapy of HP cells for treatment or prevention of HIV infection.
Patent NZ-531667-A (NZ)
Title: Pro1755 polypeptides and sequences thereof with homology to transmembrane proteins
Inventor: BAKER KEVIN
IPC: C12N15/12
Filed: 1999-09-01
Abstract: An isolated nucleic acid having at least 80% sequence identity to a nucleotide sequence that encodes a polypeptide designated PRO1755 comprising the amino acid sequence SEQ ID NO:352 is described. Preferably the nucleic acid comprises the sequence of SEQ ID NO:351 or is that deposited under accession number ATCC 203471. Vectors, isolated host cells, processes for preparing the polypeptide, pharmaceutical compositions and antibodies are also described. (62) Divided out of 510464
Patent NZ-536468-A (NZ)
Title: Apparatus for lighting a patient monitor front panel
Inventor: SMITH TOBY E
IPC: G08B21/02
Filed: 2003-04-17
Abstract: Disclosed is an electronic patient monitor that includes indirect lighting of its control panel. Preferably, a splash guard is affixed to the monitor in a position proximate to one or more light sources, none of which directly illuminate the control panel. Light from the light sources is received by the splash guard and transmitted internally to the control panel, where the light that is emitted from the splash guard provides illumination for the user.
Patent NZ-537145-A (NZ)
Title: Charged particle beam generator
Inventor: EASTHAM DEREK ANTHONY
IPC: H01J37/28
Filed: 2003-06-16
Abstract: A source of electrons is a nanotip in a vacuum as used in near field microscopy. A source of ions is a similar nanotip in vacuum supplied with liquid metal (gallium) as in a liquid-metal ion source. Electrons or ions from this nanometre-sized tip are extracted by centralising the tip over an aperture plate and applying a suitable voltage to the tip. The electrons (ions) pass through this plate and are accelerated up to several KeV using a nanoscale/microscale accelerating column before being focussed using further microscale (or nanoscale) cylindrical lenses. The final element is an aberration corrected miniature (or sub-miniature) Einzel lens which can focus the beam at several millimetres from the end of the instrument.
Patent NZ-537944-A (NZ)
Title: Oral administration of calcitonin prior to the consumption of food
Inventor: AZRIA MOISE
IPC: A61K38/22
Filed: 2003-07-31
Abstract: Disclosed herein is a use of a pharmaceutical composition for the manufacture of a medicament for the treatment of a disorder responsive to the action of calcitonin, said composition comprising calcitonin in combination with one or more oral delivery agents and whereas said composition is adapted for oral administration to a human host prior to the consumption of food. Also disclosed is an oral pharmaceutical composition comprising: (a) an oral delivery agent being the disodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid, N-(10-hydroxybenzoyl]aminodecanoic acid or N-(8-hydroxybenzoyl]amino)caprylic acid, or a hydrate or solvate of a said disodium salt; and (b) about 0.1-2.5 mg of calcitonin; in which the ratio of the amount of the oral delivery agent, expressed as the corresponding amount of free acid, to the amount of calcitonin is in the range of about 10 to about 250:1 by weight.
Patent NZ-539698-A (NZ)
Title: Kiwifruit seed oil extraction method and product
Inventor: DONALDSON BRUCE WILLIAM
Filed: 2005-04-29
Abstract: The disclosed process of producing kiwifruit seed oil involves first sterilizing the picked and selected ripe kiwifruit by flame, chlorine wash, or ozone impregnated water wash, followed by a fresh water rinse. The fruit is then cut using a water laser to minimize seed damage. Next the skin is separated from the fruit. Then the pulp is gently separated from the seed ensuring minimal seed coat damage. The resulting seed is cleaned whilst ensuring minimal seed coat damage. The seed is then dried using low temperature drying (such as freeze drying). The seed is stored at a cool temperature until it is needed for oil extraction. Crushing of the seed takes place immediately prior to the super critical extraction process. Super critical extraction using liquid carbon dioxide then extracts the kiwifruit oil from the crushed seeds. The oil is then stabilized using a natural antioxidant such as rosemary oil. The stabilized oil can then be (a) encapsulated into soft cap gelatin capsules or (b) emulsified and then dried onto a carrier base using a low temperature drying process or (c) used in the production of a food product.
Patent NZ-539987-A (NZ)
Title: Process to minimize loss through adhesion to equipment surfaces
Inventor: CAWTHORNE SIMON
IPC: A61K31/167
Filed: 2003-11-13
Abstract: A process for preparing combination formulations of inhaled glucocorticoids and beta 2-agonists, e.g. budesonide in combination with formoterol. The process aims at minimizing adhesion of one or more of the ingredients to equipment surfaces by adding the ingredients to a container in a stepwise manner wherein, preferably, the component having the largest mass is added first.
Patent NZ-545178-A (NZ)
Title: Method for the manufacture of the gaboxadol compound 4,5, 6,7-tetrahydroisoxazolo[5,4-c9]pyridin-3-ol (THIP)
Inventor: PETERSEN HANS
IPC: C07D498/04
Filed: 2004-09-01
Abstract: The disclosure relates to a method of preparing gaboxadol compound 4, 5, 6, 7-tetrahydroisoxazolo[5,4-c9]pyridin-3-ol (THIP) useful in the treatment of sleeping disorders. In particular a method of preparing THIP comprising reacting a compound of formula (8b) wherein the substituents are defined in the specification or a salt thereof with an acid, typically a mineral acid, to obtain THIP as an acid addition salt. The present disclosure also relates to several intermediates.
Patent NZ-546677-A (NZ)
Title: Solid amorphous dispersions of an MTP inhibitor for treatment of obesity
Inventor: FRIESEN DWAYNE THOMAS
IPC: A61K9/16
Filed: 2004-11-01
Abstract: Disclosed is a solid amorphous dispersion comprising (S)-N-{2[-benzyl(methyl)amino]-2-oxo-1-phenylethyl}-1-methyl-5-[4'-(trifluoromethyl)[1,1'biphenyl]-2-carboxamido]-1H-indole-2-carboxamide of Formula (I) and a polymer, wherein said compound is present in an amount of at least about 40 wt% of said solid amorphous dispersion.
Patent NZ-547191-A (NZ)
Title: Treatment of proliferative diseases using an antisense IAP oligomer and chemotherapeutic agent
Inventor: LACASSE ERIC
IPC: A61K31/4745
Filed: 2004-10-29
Abstract: Provided is the use of a nucleobase oligomer comprising the sequence of 5'- UGCACCCTGGATACCAUUU-3' (SEQ ID NO: 151) in the manufacture of a medicament for the treatment of cancer to be administered in combination with a chemotherapeutic agent selected from the imatinib, ZD1839, vinblastine, vincristine, vindesine, vinflunine, anhydrovinblastine, docetaxel, idarubicin, an antimetabolite carboplatin, and satraplatin.
Patent NZ-549250-A (NZ)
Title: An implant for bone tissue using a stepped profile and a liquefiable material to connect the implant to the bone
Inventor: MAYER JORG
IPC: A61B17/86
Filed: 2005-01-28
Abstract: An osseous implant (10) is disclosed. The implant is implanted in a predetermined cavity or cavity that has been specifically produced, parallel to an implant axis without a significant degree of rotation. The implant has cutting edges (14), which do not lie on a common plane with the implant axis and are oriented towards the distal end of the implant. In addition, the implant comprises surface areas (16) consisting of a material that can be liquefied by means of mechanical vibrations. The cutting edges (14) are dimensioned in such a way that once implanted, they cut into the cavity wall. To carry out the implantation, the implant is subjected to mechanical vibrations, causing the thermoplastic material to liquefy at least partially and be pressed into uneven areas and pores of the cavity wall, where it hardens to form a connection between the implant (10) and the cavity wall by means of a positive fit and/or a union of materials. The cutting edges (14) provide anchorage for the implant in the cavity wall, in a similar manner to a screw-type implant. As the implant requires no rotation, the implant can have a form that is neither cylindrical nor conical and can thus be stabilised against rotative stresses more effectively than a screw-type implant. The implant is also more stable with regard to tensile forces as a result of the anchorage by means of the liquefiable material and can, in particular, be subjected to stress immediately after implantation. The implant is, for example, a dental implant.
Patent NZ-551313-A (NZ)
Title: Use of meloxicam formulations in veterinary medicine
Inventor: FRITON GABRIELE
IPC: A61K9/00
Filed: 2005-04-22
Abstract: Disclosed is the use of a formulation comprising meloxicam or a pharmacologically acceptable meloxicam salt of an organic or inorganic base, one or more vehicles and one or more suitable additives for preparing a veterinary medical composition for intramammary treatment of inflammatory diseases in mammals, especially for the treatment of mastitis (inflammation of the mammary gland) in food-producing animals such as dairy cattle.
Patent NZ-551411-A (NZ)
Title: System and method for disseminating color ink and colorant formulas
Inventor: RICH DANNY
IPC: G06F17/30
Filed: 2005-05-20
Abstract: A method for providing a selection of at least one color ink formula that is suitable to produce a color for a colored print, where producing the color is based on at least one criteria, is disclosed. The method includes: (a) electronically providing a number of colors and a number of criteria; (b) electronically providing a number of color ink formulas, each of the color ink formulas capable of defining a color ink suitable for producing at least one color for at least one colored print and based on the at least one criteria; (c) electronically making a color selection from the colors; (d) electronically making a selection of at least one of the criteria; and (e) electronically matching the selected color and the selected criteria, wherein the method is halted and a user notified if the method is incapable of electronically matching the selected color and the selected criteria, thereby allowing for the selection of the color ink formula that is suitable to produce the color.
Patent NZ-551834-A (NZ)
Title: Milking device with a thermoplastic flexible teat-receiving sleeve
Inventor: PETTERSSON TORBJORN
IPC: B29C45/16
Filed: 2005-06-01
Abstract: Disclosed is a milking device which includes a teat-receiving flexible sleeve adapted to be positioned on or over a teat. The sleeve includes a first portion consisting of a thermoplastic elastomer as defined in ISO 18064, and a second portion consisting of a thermoplastic material. A method of manufacturing the milking device is also claimed.
Patent NZ-555480-A (NZ)
Title: Storage bag with evacuation device
Inventor: BORCHARDT MICHAEL G
IPC: B65B1/04
Filed: 2005-12-16
Abstract: A system for storing food includes a storage bag 900 including a flexible sidewall 902 and a one-way valve 930 attached to the flexible sidewall and communicating with the interior 906 of the bag volume. The bag includes a non-woven material barrier element 950 for separating liquids from air that covers the valve. The system includes an evacuation device including a housing having an inlet opening adapted to be placed adjacent the sidewall about the valve element.
Patent NZ-555654-A (NZ)
Title: Over dosage indicating medicated film strip
Inventor: LERNER KEITH SCOTT
Filed: 2005-11-03
Abstract: A stack of at least two layers of an edible translucent film is disclosed. The film contains a unit dosage of a medication and each film within the stack has an indicator (74, 78) in the form of a unique marking, shape, cut-out, wording, colour, texture, or other indicia to show when one or more adjacent film layers (72, 76) have been extracted. The superposition of indicators from adjacent layers provides a warning (82) to the user as to whether or not an appropriate dosage has been extracted.
Patent NZ-556332-A (NZ)
Title: Cushioning element for mill liner
Inventor: RICARDO ABARCA MELO
IPC: B02C17/22
Filed: 2006-01-16
Abstract: A liner assembly for a grinding mill, the grinding mill including a drum shaped shell having an inner surface, the shell being mounted for rotation about its central axis. The liner assembly includes a mounting element having a side wall, an end wall and a recess therein, the cushioning element being located within the recess, and a wear element operatively connected to the cushioning element. The cushioning element includes a cushion body of elastomeric material including a side section and opposed end sections. A plurality of cavities within the cushion body extend from at least one of the end sections towards the other end section. A cushioning element is also disclosed.
Patent NZ-565558-A (NZ)
Title: Device for identification of a gas cartridge for a gas-powered fastening device where the apparatus comprises the device and the cartridge for the apparatus
Inventor: CALVET PIERRICK
IPC: B25C1/08
Filed: 2006-07-01
Abstract: A gas-powered fastening apparatus comprises a combustion chamber, a transmission device 30 comprising of a valve 39 and a solenoid 38 for controlling the valve 39 and thereby the transmission of gas from a gas cartridge 20 into the combustion chamber, and an identification device for identifying an electronic identification label 50 of the gas cartridge 20. The identification device comprises reading means 38, 46, 47 for reading the data of the electronic identification label 50 of the gas cartridge 20. The reading means 38, 46, 47 comprises a receiver antenna constituted of the solenoid 38, where the solenoid 38 cooperates with a broadcast antenna 51 of the label 50 to receive the data.
Patent NZ-568945-A (NZ)
Title: Personalised video generation
Inventor: GRUBER DANNY
IPC: G06Q10/00
Filed: 2006-11-10
Abstract: A personalised video generation system is disclosed. The system includes: a digital asset manager for storing a video project file marked with references to content groups and content substitution rules; an editing tool for accessing the file and displaying content of the file grouped based on the groups, and generating an interface for substituting content across a video corresponding to the file, the interface adjusting the references for the digital asset manager; and a content generation engine for processing the file and the rules, based on personal data for intended recipients, to access content items and generating a number of video project files for rendering as corresponding videos for the recipients.
Patent NZ-569922-A (NZ)
Title: Compressor device with a temperature controlled speed limiting circuit
Inventor: SMETS ALEXANDER ANTOON FRANS M
IPC: F04B49/20
Filed: 2007-01-18
Abstract: Disclosed is a compressor device. The device includes a case containing a compressor element which is powered by a variable speed motor with a control box that controls the motor to provide a maximum number of revolutions per minute for the compressor element. The device includes an air cooling means which sucks environmental air via an inlet and blows it back to the environment through the case and via an exhaust and a cooling circuit for the cooling of a gas which has been compressed by the compressor element. A means for measuring environmental air temperature is operatively coupled to the control box. The control box is programmed with an algorithm which causes the motor to reduce the maximum number of revolutions per minute by a certain level as soon as the measured environmental temperature rises above a maximum set level and to increase the maximum number of revolutions per minute as soon as the environmental temperature falls below the maximum set level.
Patent NZ-570359-A (NZ)
Title: Heat shrinkable multilayer film for packaging
Inventor: ISHII HITOSHI
IPC: B32B27/28
Filed: 2007-01-15
Abstract: Disclosed is a heat shrinkable multilayer film comprising an outer surface layer (a) formed of a thermoplastic resin, a first intermediate layer (b1) formed of a polyamide resin, a second intermediate layer (b2) formed of a saponified product of an ethylene-vinyl acetate copolymer, and an inner surface layer (c) formed of a polyolefin resin, wherein the shrink of the heat shrinkable multilayer film in water at 90 Deg. C is within a range of from 3 to 45% in each of machine and transverse directions, the polyamide resin is a mixture of 60 to 90% by weight of an aliphatic polyamide having a melting point of 210 Deg. C or higher and 10 to 40% by weight of an aromatic polyamide comprising isophthalic acid and terephthalic acid as acid components, and the multilayer film is obtained by stretching a multilayer film comprising the outer surface layer (a), the first intermediate layer (b1) I the second intermediate layer (b2) and the inner surface layer (c) at a draw ratio of from 2.5 to 4 times in each of machine and transverse directions and then subjecting the stretched film to a heat relaxation treatment so as to give a relaxation ratio of from 2 to 40%. This heat shrinkable multilayer film is useful as, for example, packaging materials for pouch, packaging materials for bag, packaging materials for pillow packaging, packaging materials for deep-draw packaging and lid materials for tray packaging.
Patent NZ-574882-A (NZ)
Title: Pharmaceutical and nutraceutical products comprising vitamin k2
Inventor: VERMEER CEES
IPC: A23L33/15
Filed: 2007-07-13
Abstract: Disclosed is the use of at least one menaquinone compound within the vitamin K2 class of compounds selected from MK-7, MK-8, MK-9 and MK-10 (pictured formula where n is 7-10), in combination with at least one n-3 polyunsaturated fatty acid, which is one of EPA (eicosapentaenoic acid)and DHA (docosahexaenoic acid), either purified or in the form of a marine oil, in the preparation of a pharmaceutical or nutraceutical product for promoting at least one of cardiovascular health, bone health and cartilage health in humans or animals. Examples of conditions and diseases treated are atherosclerosis, arteriosclerosis, osteoporosis, osteoarthritis or an inflammatory or degenerative disease of the cartilage.
Patent NZ-577651-A (NZ)
Title: Synchronized broadcast/multicast communication
Inventor: BLACK PETER J
IPC: H04B7/26
Filed: 2005-01-20
Abstract: An apparatus for synchronized broadcast, comprises means for receiving a first transmission slot; means for identifying a portion of the first transmission slot comprising a synchronized broadcast content modulated using a first modulation format having a spreading code common to multiple transmitters and a unicast portion modulated using a second modulation format; means for demodulating the unicast portion; and means for demodulating the broadcast portion. The first and second modulation formats are different. A method for synchronized broadcast is also disclosed. (62) Divided Out of 571456